IGF1 and metabolic disease: Endocrine and metabolic disorders: All children received GH treatment at the same recommended dose, and median IGF-1 levels were in the normal range with significantly higher values in the OT-exposed group compared to the non-exposed group (198 ng/mL vs. 132 ng/mL, p = 0.01).